Skip to main content
APhA 2024 Annual Meeting and Exposition Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
View Session ViewAttendees 23

Medication Management

Diabetes Management

Virtual

Weight Management: Rise of the Resistance

Friday, March 22, 2024
1:00 PM – 2:30 PM East Coast USA Time
Location: Orange County Convention Center, W311GH
CE: 1.5

ACPE Number: 0202-0000-24-042-L01-P

Number of Hours: 1.5

Activity Type: Knowledge

Disclosure(s):
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM: Embecta: Advisory Committee/Board Member (Terminated, December 31, 2023); Novo Nordisk: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Xeris: Consultant (Terminated, December 31, 2023)
Embark on an enlightening journey as we delve into the realm of weight loss drug case studies, uncovering real-world successes and insights. Explore the multifaceted landscape of challenges these medications face, from efficacy and safety to regulatory and drug supply hurdles. Attend this session to learn to navigate the complexities of the weight loss pharmaceutical landscape.

Learning Objectives:

  • Compare and contrast current FDA approved medications for weight management
  • Provide currently available evidence based real world data on the weight loss medications
  • Interpret the real-world data to develop clinical recommendations, given a case scenario
  • Describe challenges and barriers of use for weight loss drugs including regulatory considerations and drug supply chain issues